As the Oncology and Rare Diseases Therapeutic Area Lead in the Clinical Data Sciences (CDS) organization at Pfizer, Catherine Célingant leads a team of Clinical Data Scientists and Data Managers responsible for timely and high-quality data management deliverables supporting the Pfizer Oncology and Rare Diseases portfolios.
Catherine has over 25 years of experience in Data Management, Clinical Informatics, and Medical Operations. Prior to joining Pfizer, Catherine worked at Millennium: The Takeda Oncology Company, where she successively led the Clinical Data Management and Clinical Systems, Medical Systems Innovative Technologies and Operations, and Medical Business Operations functions.
Catherine also worked at Accenture, Wyeth, Genetics Institute, and MTRA (AAI). Over the years, Catherine has been involved in several PhRMA, eClinical Forum and Transcelerate-sponsored groups working with other bio-pharmaceutical sponsors, regulators and other stakeholders to facilitate the adoption of research-enabling technologies such as EDC, ePRO, and eSource. Catherine holds a M.A. in Linguistics from Cornell University and an undergraduate degree in Biology from the University of Bordeaux, France.